GlucoModicum Ltd

medical devices

About

GlucoModicum Ltd is a medical technology company dedicated to advancing glucose monitoring with its innovative needle-free magnetohydrodynamic technology. The company's flagship product, the Talisman sensor, non-invasively measures glucose levels by sampling interstitial fluid through the skin. This approach offers a rapid and gentle alternative to traditional continuous glucose monitoring (CGM) devices, which typically require invasive sensors. The Talisman sensor has shown strong correlation to blood glucose levels in clinical studies, aiming to enhance user comfort and adherence. GlucoModicum is focused on large-scale manufacturing and commercialization of this technology, targeting individuals who need continuous glucose monitoring, particularly those with diabetes. The company is committed to improving the quality of life for users by providing a more user-friendly and precise monitoring solution.

Technologies

Outlook Mobile Friendly Google Tag Manager WordPress.org reCAPTCHA Bootstrap Framework

Keywords

mass-produced sensors d2c biosensor integration sensor miniaturization interstitial fluid sampling government clinical performance study non-invasive glucose measurement medical equipment and supplies manufacturing iot glucose sensor remote patient monitoring services healthcare regulatory compliance sensor calibration physics healthcare innovation wearable technology b2b predictive analytics data analytics healthcare technology mass manufacturing ultra-sensitive biosensors non-invasive diabetes monitoring eu mdr compliance risk management diabetes care diabetes management

Location

1 A. I. Virtasen aukio, Helsinki, Uusimaa, Finland, 00560

Related Companies

Companies in the same industry